Avandia Diabetes Treatment

FDA Approval of Treatment for Type 2 Diabetes

According to information provided on the Food and Drug Administration's website, Avandia gained approval in 1999 for treatment of type 2 diabetes.

Since then, the FDA has been monitoring several heart-related adverse events. Other medical issues associated with Avandia include fluid retention and edema, the FDA said.

These findings, the agency reports, were based on previous clinical trials of Avandia alone and in combination with other drugs, and from postmarketing reports.

The FDA has updated the product's labeling on several occasions. The most recent labeling change for Avandia also included a new warning about a potential increase in heart attacks and heart-related chest pain in some individuals using Avandia. This new warning was based on the result of a clinical trial in patients with existing congestive heart failure.

If you or a loved one has suffered cardiac complications after ingesting Avandia, you deserve the guidance of an experienced drug attorney. Get a free case review by filling out the form below.

Click To Talk To Us Online

avandia drug warning

Avandia drug has heart-related risk, FDA warning
FDA warning: cardiovascular risks associated with use of Avandia drug.

FDA News

FDA Releases New Safety Info on Diabetes Drug Avandia and Side Effects
FDA Updates Public on Safety Information for Avandia and Side Effects

Name

Phone

strictly confidential

Your Question

Contact Name
Email Address
Phone Number
When did you start taking Avandia?
Did you experience cardiovascular problems after taking Avandia?
What was the date you experienced cardiac complications?
Did you have any cardiovascular disease before taking Avandia?
Did you suffer a bone fracture after taking either Avandia or Actos?
Please provide detail about your bone fracture injury, including the date of the injury, how the fracture occured and what bone(s) were affected.
Additional information